Momenta Pharmaceuticals, Inc. (MNTA)


Stock Price Forecast

Sept. 30, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Momenta Pharmaceuticals, Inc. chart...

About the Company

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Biotechnology

Employees

118

$30M

Total Revenue

118

Employees

$6B

Market Capitalization

-24.64

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $MNTA News

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10d ago, source: Business Wire

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on March 8, 2024, the ...

Zenas BioPharma Appoints Patricia Allen to its Board of Directors

12d ago, source:

We are pleased to welcome Patty to our Board of Directors,” said Lonnie Moulder, Founder and Chief Executive Officer of Zenas BioPharma. “She has successfully led cross-organizational functions and ...

Are You Looking for a Top Momentum Pick? Why Y-mAbs Therapeutics, Inc. (YMAB) is a Great Choice

13d ago, source: Zacks.com on MSN

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Amring Pharmaceuticals Appoints Renowned Ophthalmologist to Lead Advisory Board Ahead of Dry Eye Therapy Launch

12d ago, source: MyChesCo on MSN

Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V. (Nordic Pharma), has announced the appointment of leading ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...